27 studies found for:    "Hepatitis D"
Show Display Options
RSS Create an RSS feed from your search for:
"Hepatitis D"
Need help? See RSS Feeds
Choose a feed type:
Show studies first received on any dateShow studies that were first received in the last 14 days
Show studies last updated date on any dateShow studies that were added or modified in the last 14 days
Rank Status Study
1 Completed
Has Results
Pegylated Interferon to Treat Chronic Hepatitis D
Condition: Hepatitis D
Intervention: Drug: Peginterferon Alpha-2a
2 Recruiting Treatment of Chronic Delta Hepatitis With Lonafarnib and Ritonavir
Condition: Hepatitis D
Interventions: Drug: Lonafarnib;   Drug: Ritonavir;   Other: Placebo
3 Completed Lonafarnib for Chronic Hepatitis D
Condition: Hepatitis D
Intervention: Drug: Lonafarnib
4 Completed A Study of Pegylated Interferon (PEG-IFN) Alfa-2a (Pegasys) in Participants With Chronic Hepatitis D (CHD)
Condition: Hepatitis D, Chronic
Intervention: Drug: Pegylated Interferon (PEG-IFN) alfa-2a
5 Completed
Has Results
A Study of Peginterferon Alfa-2a With or Without Ribavirin in Participants With Chronic Hepatitis D (CHD)
Condition: Hepatitis D, Chronic
Interventions: Drug: Peginterferon alfa-2a;   Drug: Ribavirin
6 Active, not recruiting An Observational Study on the Prevalence of Chronic Hepatitis D in Romania and the Efficacy of Treatment With Pegasys (Peginterferon Alfa-2a)
Condition: Hepatitis D, Chronic
Intervention:
7 Recruiting Mother-to-child Hepatitis D Transmission
Conditions: Hepatitis D;   Transmission
Intervention:
8 Terminated Proof-of-concept Study Evaluating the Safety and Efficacy of EBP921 in Delta Hepatitis (HDV)
Condition: Hepatitis D
Intervention: Drug: EBP921
9 Recruiting The Hepatitis Delta International Network
Condition: Hepatitis D
Intervention:
10 Active, not recruiting A Study of Pegasys (Peginterferon Alfa 2a) Alone or in Combination With Tenofovir in Patients With Chronic Hepatitis D.
Condition: Hepatitis D, Chronic
Interventions: Drug: peginterferon alfa-2a [Pegasys];   Drug: placebo;   Drug: tenofovir
11 Active, not recruiting HIDIT II - PegIFN-alfa2a Plus Tenofovir in Chronic Delta Hepatitis
Condition: Hepatitis D
Interventions: Drug: PEG-IFN alfa-2a, Tenofovir;   Drug: PEG-IFN alfa-2a, placebo
12 Recruiting A Study to Evaluate Pegylated Interferon Lambda Monotherapy in Patients With Chronic Hepatitis Delta Virus Infection
Condition: Hepatitis D, Chronic
Intervention: Drug: Lambda
13 Active, not recruiting Myrcludex B Plus Pegylated Interferon-alpha-2a in Patients With Chronic Hepatitis Delta
Condition: Chronic Hepatitis D Infection
Interventions: Drug: Myrcludex B;   Drug: pegINF
14 Completed Lamivudine for Chronic Hepatitis B
Conditions: Chronic Hepatitis B;   Chronic Hepatitis D;   Glomerulonephritis;   Polyarteritis Nodosa
Intervention: Drug: Lamivudine
15 Recruiting Lonafarnib With Ritonavir in HDV (LOWR-2)
Condition: Chronic Hepatitis D Infection
Interventions: Drug: lonafarnib;   Drug: Ritonavir;   Drug: PEG IFN-a
16 Completed Lonafarnib With and Without Ritonavir in HDV (LOWR-1)
Condition: Chronic Hepatitis D Infection
Interventions: Drug: lonafarnib;   Drug: PEG IFN-a;   Drug: Ritonavir
17 Completed
Has Results
Efficacy of Peginterferon Alfa-2b in Previously Untreated Subjects With Chronic Hepatitis B and D Co-infection (Study P04603)
Conditions: Hepatitis D, Chronic;   Hepatitis B, Chronic
Intervention: Biological: Peginterferon alfa-2b (PegIntron, SCH 54031)
18 Recruiting A Long Term Follow-up Study of Patients From the REP 301 Protocol
Conditions: Hepatitis B, Chronic;   Hepatitis D, Chronic
Intervention:
19 Unknown  Pegylated Interferon Alfa-2b Plus Ribavirin in Chronic Hepatitis B and Delta
Conditions: Chronic Hepatitis B;   Chronic Hepatitis D
Intervention: Drug: pegylated IFN alfa-2b plus ribavirin
20 Active, not recruiting Titrating-Dose of Lonafarnib in Combination With Ritonavir
Condition: Chronic Delta Hepatitis
Interventions: Drug: lonafarnib;   Drug: Ritonavir

   Previous Page Studies Shown (1-20) Next Page (21-27) Show next page of results    Last Page
Indicates status has not been verified in more than two years